Navigation Links
Siemens MAGNETOM Spectra 3T MRI System Receives FDA Clearance
Date:7/24/2012

enters and clinics to benefit from high imaging quality for their clinical routine.

The MAGNETOM Spectra system also consumes less energy than other 3T scanners. Furthermore, the magnet-cooling helium is contained in a closed loop, preventing the gas from escaping and reducing the need for costly refills. In addition, various components of the MAGNETOM Spectra help technologists simplify the MRI examination process. For example, the cableless direct-connect coils allow for simple and quick setup, with up to 120 coil elements capable of being combined in a flexible manner. For this reason, even large scans with large anatomical coverage up to whole-body scans (205 cm, or 80.71 inches) can be performed in one examination without patient or coil repositioning.

The MAGNETOM Spectra system can be used for a broad spectrum of applications, from diagnosing damaged ankle cartilage to conducting dynamic abdominal examinations to performing functional brain imaging. To reduce exam complexity, the MAGNETOM Spectra is equipped with Siemens' MRI workflow solution Dot (Day optimizing throughput), which enables easy, fast selection of the best scan strategy based on the patient's condition and the clinical indication. Users benefit from step-by-step guidance throughout the examination, receiving decision-making assistance at critical junctures to support consistent, reproducible scanning across patients. Thanks to Siemens' Tim and Dot technologies, high-quality images can be produced in less time.

Launched by Siemens Healthcare Sector, Agenda 2013 is a two-year global initiative to further strengthen the Healthcare Sector's innovative power and competitiveness. Specific measures will be implemented in four fields of action: Innovation, Competitiveness, Regional Footprint, and People Development.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, m
'/>"/>

SOURCE Siemens Healthcare
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sysmex and Siemens Renew Global Partnership for Hemostasis Solutions and Services
2. Siemens Launches Next Generation Automation Solution Aptio at AACC 2012
3. Siemens Unveils New Solutions and Latest Innovations at AACC 2012
4. Frost & Sullivan Recognizes Siemens Healthcares CT Imaging Solution for the Value it Offers Both Service Providers and Patients
5. Siemens SOMATOM Definition Edge Single-Source CT Cleared for Sale in U.S.
6. FDA Clears New Siemens SOMATOM Perspective CT Scanner
7. At SIIM 2012 Siemens Healthcare Demonstrates Departmental IT Solutions That Help Administrators Increase Access while Managing Costs
8. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
9. Global Central Nervous System Drugs Market 2011-2015
10. Lifeline Biotechnologies First Warning Systems
11. FDA clears Accu-Chek Combo system - Roches new interactive insulin pump system for people with diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ZIONA, Israel , June 29, ... BVXV, TASE: BVXV) today announced positive preliminary results from ... candidate for a universal influenza vaccine. In this trial, ... of 50 to 65, followed by an administration of ... later. M-001 was found to be safe and well ...
(Date:6/29/2015)... Calif. , June 29, 2015  Isis Pharmaceuticals, ... has been added to the Russell 1000 Index, effective ... performance of the large-cap segment of the U.S. equity ... Index and includes approximately 1000 of the largest securities ... current index membership. "We are pleased to ...
(Date:6/29/2015)... Calif. , June 29, 2015  Arbor ... medical workstation lineup. The high-powered, multi-functional M2150 ... generation Intel® Haswell Core i5-4402E 1.6 ... provide significant data processing and computing performance. Integrated ... making the unit well suited for graphics-intense applications ...
Breaking Medicine Technology:BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... Ouchless ® Needle by BellaNovus Development Company ... Dr. Mariano Busso is the latest in a growing ... its use for cosmetic injections. Dr. Busso is on ... localized pain resulting from cosmetic injections. Ouchless ® ...
... a critical care company focused on developing and commercializing ... the U.S. Food and Drug Administration (FDA) has granted ... oxide (iNO) with the INOpulse® DS drug-delivery system as ... investigational new drug application (IND) for PAH was submitted ...
Cached Medicine Technology:New Ouchless® Needle Collection Announces Leading Dermatology Testimonial 2FDA Grants Orphan Drug Designation to Ikaria® For Use of Inhaled Nitric Oxide in Pulmonary Arterial Hypertension 2FDA Grants Orphan Drug Designation to Ikaria® For Use of Inhaled Nitric Oxide in Pulmonary Arterial Hypertension 3FDA Grants Orphan Drug Designation to Ikaria® For Use of Inhaled Nitric Oxide in Pulmonary Arterial Hypertension 4
(Date:6/29/2015)... ... June 29, 2015 , ... ... series as part of its support program. This discussion series is part of ... other support services to those affected by mesothelioma. , The six week discussion ...
(Date:6/29/2015)... ... 2015 , ... The Society for Immunotherapy of Cancer (SITC) ... accelerated approval of Bristol-Myers Squibb’s Opdivo® (nivolumab) for the treatment of metastatic melanoma. ... nivolumab for patients with metastatic melanoma in Europe represents a major advance in ...
(Date:6/29/2015)... , ... June 29, 2015 , ... ... now being offered at NewYork-Presbyterian/Weill Cornell Medical Center. The device is the first ... an alternative to continuous positive airway pressure (CPAP), the current standard of care ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... , **FDAnews Webinar**, July 16, 2015 — 1:30 p.m. – 3:00 p.m. EDT, ... application of human factors engineering to the design of new products as well ...
(Date:6/29/2015)... York, NY (PRWEB) , ... June 29, 2015 ... ... Mount Sinai have developed a new approach to build nearly complete genomes by ... complex forms of genomic variation, critically important for their association with human disease, ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Organization Provides Support for Patients and Families 2Health News:Mesothelioma Organization Provides Support for Patients and Families 3Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 2Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 3Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 2Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 3Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 4Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 2Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4
... , , , , , ... AUDIO: Scientists at Washington University School of Medicine in St. Louis have found a ... Click here for more information. , , , ... , , , , , ...
... European Society of Cardiology (ESC) is concerned that interpretations ... Lancet (1), could act to deter ongoing research ... density lipoprotein (HDL) cholesterol. Caution, the ESC experts ... results. In the Lancet study, Paul ...
... of the global AIDS community concluded today with clear ... scale up, yet facing an urgent need for increased ... of ,scientifically sound prevention strategies. Delegates and organizers depart ... the theme of Rights Here, Right Now -- with ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, July ... airborne fungus that can cause life-threatening illness -- is an ... Thursday. While C. gattii infections are rare ... they can be severe and even fatal, researchers at the ...
... THURSDAY, July 22 (HealthDay News) -- In small theater ... learning that acting can be a powerful form of therapy, ... deeply personal accounts of mental health issues. "Theater arts ... piece their lives back together," said David A. Faigin, department ...
... happy hour. He sidles up to the bar and orders a ... drink yourself? According to new findings reported in Psychological Science ... determine the extent to which you are influenced by social drinking ... and seeing other people around you drinking. Drinking alcohol increases ...
Cached Medicine News:Health News:Inhibiting fatty acids in immune cells decreases atherosclerosis risk 2Health News:Inhibiting fatty acids in immune cells decreases atherosclerosis risk 3Health News:Inhibiting fatty acids in immune cells decreases atherosclerosis risk 4Health News:No firm conclusions about HDL cholesterol can be drawn from JUPITER sub-analysis 2Health News:No firm conclusions about HDL cholesterol can be drawn from JUPITER sub-analysis 3Health News:Strong scientific findings presented at AIDS 2010 point to promise ahead and underscore the need to stay the course 2Health News:Strong scientific findings presented at AIDS 2010 point to promise ahead and underscore the need to stay the course 3Health News:Strong scientific findings presented at AIDS 2010 point to promise ahead and underscore the need to stay the course 4Health News:Dangerous Fungus Now Endemic in Pacific Northwest: CDC 2Health News:Dangerous Fungus Now Endemic in Pacific Northwest: CDC 3Health News:Taking to the Stage to Battle Mental Illness 2Health News:Taking to the Stage to Battle Mental Illness 3Health News:Taking to the Stage to Battle Mental Illness 4Health News:Can I buy you a drink? Genetics may determine sensitivity to other people's drinking behavior 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: